A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma

Clinical trial NCT01881529 · COMPLETED

Trial details

NCT number: NCT01881529
Sponsor: Gilead Sciences
Status: COMPLETED
Study type: OBSERVATIONAL

Limited Scleroderma Diffuse Scleroderma

Start date: 2013-04-01
Primary completion: 2014-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.